Cargando…

In vivo and in vitro models of demyelinating diseases: XII. Persistence and expression of corona JHM vims functions in RN2-2 Schwannoma cells during latency

The coronavirus JHMV persistently infects rat Schwannoma cells RN2-2 at 32.5°C and enters a host-imposed reversible, latent state at 39.5°C. JHMV can remain up to 20 days in the latent state and about 14 days before the cultures lose the capacity to resume virus production upon return to 32.5°C. Alt...

Descripción completa

Detalles Bibliográficos
Autores principales: Coulter-Mackie, Marion, Adler, Richard, Wilson, Greame, Dales, Samuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 1985
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7134134/
https://www.ncbi.nlm.nih.gov/pubmed/3000100
http://dx.doi.org/10.1016/0168-1702(85)90049-8
_version_ 1783517773864894464
author Coulter-Mackie, Marion
Adler, Richard
Wilson, Greame
Dales, Samuel
author_facet Coulter-Mackie, Marion
Adler, Richard
Wilson, Greame
Dales, Samuel
author_sort Coulter-Mackie, Marion
collection PubMed
description The coronavirus JHMV persistently infects rat Schwannoma cells RN2-2 at 32.5°C and enters a host-imposed reversible, latent state at 39.5°C. JHMV can remain up to 20 days in the latent state and about 14 days before the cultures lose the capacity to resume virus production upon return to 32.5°C. Although persistently and latently infected RN2-2 cells display resistance to superinfection by a heterologous agent VSV, these cells do not release detectable soluble mediators (e.g., interferon) of the antiviral state. Nevertheless, RN2-2 cells are competent to synthesize and release interferon when treated with the appropriate inducers. These observations suggest that interferon does not play any role or may not be the major factor in the control of latency in the Schwannoma cell. Hybridization with virus-specific cDNAs shows that all viral mRNAs are present during latency and that viral mRNAs are present in the polysomes of infected cells at 39.5°C. Western immunoblotting with hybridoma antibodies demonstrates that viral specific proteins are produced at the restrictive temperature. These results
format Online
Article
Text
id pubmed-7134134
institution National Center for Biotechnology Information
language English
publishDate 1985
publisher Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-71341342020-04-08 In vivo and in vitro models of demyelinating diseases: XII. Persistence and expression of corona JHM vims functions in RN2-2 Schwannoma cells during latency Coulter-Mackie, Marion Adler, Richard Wilson, Greame Dales, Samuel Virus Res Article The coronavirus JHMV persistently infects rat Schwannoma cells RN2-2 at 32.5°C and enters a host-imposed reversible, latent state at 39.5°C. JHMV can remain up to 20 days in the latent state and about 14 days before the cultures lose the capacity to resume virus production upon return to 32.5°C. Although persistently and latently infected RN2-2 cells display resistance to superinfection by a heterologous agent VSV, these cells do not release detectable soluble mediators (e.g., interferon) of the antiviral state. Nevertheless, RN2-2 cells are competent to synthesize and release interferon when treated with the appropriate inducers. These observations suggest that interferon does not play any role or may not be the major factor in the control of latency in the Schwannoma cell. Hybridization with virus-specific cDNAs shows that all viral mRNAs are present during latency and that viral mRNAs are present in the polysomes of infected cells at 39.5°C. Western immunoblotting with hybridoma antibodies demonstrates that viral specific proteins are produced at the restrictive temperature. These results Published by Elsevier B.V. 1985-10 2002-11-12 /pmc/articles/PMC7134134/ /pubmed/3000100 http://dx.doi.org/10.1016/0168-1702(85)90049-8 Text en Copyright © 1985 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Coulter-Mackie, Marion
Adler, Richard
Wilson, Greame
Dales, Samuel
In vivo and in vitro models of demyelinating diseases: XII. Persistence and expression of corona JHM vims functions in RN2-2 Schwannoma cells during latency
title In vivo and in vitro models of demyelinating diseases: XII. Persistence and expression of corona JHM vims functions in RN2-2 Schwannoma cells during latency
title_full In vivo and in vitro models of demyelinating diseases: XII. Persistence and expression of corona JHM vims functions in RN2-2 Schwannoma cells during latency
title_fullStr In vivo and in vitro models of demyelinating diseases: XII. Persistence and expression of corona JHM vims functions in RN2-2 Schwannoma cells during latency
title_full_unstemmed In vivo and in vitro models of demyelinating diseases: XII. Persistence and expression of corona JHM vims functions in RN2-2 Schwannoma cells during latency
title_short In vivo and in vitro models of demyelinating diseases: XII. Persistence and expression of corona JHM vims functions in RN2-2 Schwannoma cells during latency
title_sort in vivo and in vitro models of demyelinating diseases: xii. persistence and expression of corona jhm vims functions in rn2-2 schwannoma cells during latency
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7134134/
https://www.ncbi.nlm.nih.gov/pubmed/3000100
http://dx.doi.org/10.1016/0168-1702(85)90049-8
work_keys_str_mv AT coultermackiemarion invivoandinvitromodelsofdemyelinatingdiseasesxiipersistenceandexpressionofcoronajhmvimsfunctionsinrn22schwannomacellsduringlatency
AT adlerrichard invivoandinvitromodelsofdemyelinatingdiseasesxiipersistenceandexpressionofcoronajhmvimsfunctionsinrn22schwannomacellsduringlatency
AT wilsongreame invivoandinvitromodelsofdemyelinatingdiseasesxiipersistenceandexpressionofcoronajhmvimsfunctionsinrn22schwannomacellsduringlatency
AT dalessamuel invivoandinvitromodelsofdemyelinatingdiseasesxiipersistenceandexpressionofcoronajhmvimsfunctionsinrn22schwannomacellsduringlatency